Form 4: Eli Lilly Director Acquires Shares Through Deferral Plan

Director Juan R. Luciano acquired 19,042 shares of Eli Lilly common stock through a deferral plan, as reported in a recent SEC filing.

Summary

• Juan R. Luciano, a director at Eli Lilly & Co, acquired 19,042 shares of common stock on December 16, 2024.
• The shares were acquired at a price of $779 per share.
• These shares were obtained through the Lilly Directors' Deferral Plan, in lieu of cash compensation.
• The shares will be settled in common stock after Mr. Luciano's separation from service.
• Following this transaction, Mr. Luciano beneficially owns 16,191.301 shares of Eli Lilly common stock.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as it reflects a director's increased stake in the company, which is generally seen as a good sign. However, it's a routine transaction, so the impact is not overly significant.

Positives

• The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future.
• The use of a deferral plan aligns the director's interests with the long-term performance of the company.

Future Outlook

The acquired shares will be settled in common stock following the reporting person's separation from service.

Industry Context

This type of transaction is common for directors of publicly traded companies, often as part of their compensation packages and to align their interests with shareholders.

Comparison to Industry Standards

• Director share acquisitions through deferral plans are a common practice among large pharmaceutical companies like Eli Lilly.
• Companies such as Pfizer, Merck, and AbbVie also utilize similar compensation structures for their directors.
• These plans are designed to incentivize long-term value creation and align director interests with shareholder value.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it indicates director confidence in the company.
• The deferral plan aligns director interests with long-term shareholder value.

Key Dates

Keywords

Eli Lilly, Director, Share Acquisition, Deferral Plan, SEC Form 4, Stock Ownership, Juan R. Luciano